RETA
Reata Pharmaceuticals Inc
Director Shamim Ruff sold $1.4M of Reata Pharmaceuticals Inc
Sold$1,354,887
$164.53Price
8,235Shares
−53%Stake
What RETA did after the filing
- The stock from Tue, Aug 1 close, $166.10
- +3.6%
- S&P 500, same days
- −2.2%
Measured over 30 trading days, to the Sep 13 close.
Traded Fri, Jul 28. Filed Tue, Aug 1, 12:41 PM ET, during the session. Returns use the Aug 1 close and the Sep 13 close. Not investment advice.